Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03522740
Other study ID # 12890
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 30, 2018
Est. completion date September 21, 2021

Study information

Verified date April 2022
Source Tufts University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Good communication among patients, their families and loved ones, and their medical care providers is important when figuring out how to treat chronic diseases like kidney disease. A lot of people may not know all of their choices for how to treat kidney disease, and this can lead to rushed decisions or even a sense that there weren't any choices to make. In this study, the investigators are trying to find out if a decision-aid program on a computer can help people with kidney disease have more confidence in their decisions and have better agreement about their decisions with their families and loved ones. The DART study will be conducted at four sites in different areas of the country: Boston, Massachusetts; Portland, Maine; Chicago, Illinois; and San Diego, California. The study will enroll a total of 400 people with kidney disease at these four sites.


Description:

Aligning patient preferences (goals of care and values) with treatment is essential for quality health care. Treatment of life-limiting illness is especially preference-sensitive, where high-intensity care often offers marginal survival benefit but can worsen quality of life. Elderly persons with advanced chronic kidney disease (CKD) may face a choice between high-intensity dialysis and low-intensity conservative management (CM). This decision is of special import because it is often irreversible as dialysis itself can diminish residual kidney function. In adults over 70 years-old with advanced CKD, dialysis on average confers only marginally better survival than medical management while reducing independence and mobility and increasing medical procedures. Poor communication about benefits and risks of treatment options available to these patients results in decisional conflict: a state of uncertainty associated with making a choice that best reflects values and preferences. However, it is unclear how to best educate patients and their care-partners about their treatment choices and the importance of advance care planning. The objective of this trial is to compare the effectiveness of two widely used strategies, in-person education alone versus in-person education plus an interactive web-based decision aid, in: 1) reducing decisional conflict and empowering patients and care-partners to select treatment aligned with patient preferences; and 2) improving care-partners' ability to confidently and accurately express patients' preferences when patients are unable (proxy decision-making). The hypothesis is that, compared to traditional in-person education, use of the Decision Aid for Renal Therapy (DART) will decrease decisional conflict, increase completion of advance directives, improve patient and caregiver satisfaction with treatment (quantitative outcomes), and contribute to greater patient engagement, satisfaction with decision-making, and care-partner concordance (qualitative and quantitative outcomes). DART is a web-based multimedia decision-aid that is designed to be accessible to individuals with limited health literacy. The investigators will evaluate whether use of DART results in greater patient understanding of options, leading to better discussions with care providers, and ultimately lower decisional conflict and greater completion of advanced directives compared with the comparator, in-person education. DART is replicable, consistent, can be shared with care-partners, and can be viewed in the comfort of the patient's home. This randomized clinical trial targeting 400 older adults with advanced kidney disease and as many as 400 of their care-partners compares the effectiveness of DART plus in-person education to in-person education alone for reducing decisional conflict and increasing completion of advance care plans (ACPs) among older adults with advanced CKD and their care-partners. Patients and patient-care-partner pairs will be surveyed at baseline for goals of care, life goals, health literacy, patient activation, end-of-life (EOL) preferences and baseline scores on other study outcome measures, and followed at 3- to 6-month intervals for up to 18 months, censoring at dialysis, death or study end, to collect data on decisional conflict and completion of advance directives as well as QOL, satisfaction, dyad concordance and medical events, such as dialysis initiation.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date September 21, 2021
Est. primary completion date September 21, 2021
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria: - CKD stages 4 or 5 (non-dialysis) without an established dialysis start or transplant date within three months of expected randomization; - Age >70 (with no upper limit); - English speaking; - Willingness to be randomized to DART; and - Able to sign informed consent. Exclusion Criteria: - death, dialysis initiation or transplant deemed highly likely within the next three months by the patient's nephrologist

Study Design


Intervention

Other:
Decision Aid for Renal Therapy
DART is a web-based decision aid that informs older adults with advanced kidney disease of kidney disease treatment options and prompts them to consider their preferences and raise questions to discuss with their kidney disease providers.

Locations

Country Name City State
United States Tufts Medical Center Boston Massachusetts
United States Northwestern University Chicago Illinois
United States Maine Medical Center Portland Maine
United States University of California San Diego San Diego California

Sponsors (2)

Lead Sponsor Collaborator
Tufts University Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Instability of Patient Preferences A reversal of the post-intervention decision (dialysis or conservative management) from the first visit after DART/3month follow-up and study completion Up to 18 months
Other Patient/Care-Partner Concordance Goal concordance as assessed on the goals of care survey Up to 18 months
Primary Change in score for patient-participants on the Decisional Conflict Scale, Low Literacy Version The decisional conflict scale (DCS) measures personal perceptions of:
Uncertainty in choosing options; and
Modifiable factors contributing to uncertainty.
The low literacy version of the DCS contains 10 items scored on a 3 point scale, with 0 points given for an answer of yes, 2 for an answer of unsure, and 4 for an answer of no.
The total DCS score is the sum of the 10 items, multiplied by 2.5. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict)
The DCS can be conceptualized as subscores, which will be examined as a part of this study, and are normalized to a 0 to 100 score as above. These include the following:
Uncertainty subscore: 2 items (questions 9 and 10)
Informed subscore: 3 items (questions 1, 2, and 3)
Values clarity subscore: 2 items (questions 4 and 5)
Support subscore: 3 items (questions 6, 7, and 8)
Reference: https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf
3 months
Secondary Change in score for patient-participants on the Decisional Conflict Scale, Low Literacy Version The decisional conflict scale (DCS) measures personal perceptions of:
Uncertainty in choosing options; and
Modifiable factors contributing to uncertainty.
The low literacy version of the DCS contains 10 items scored on a 3 point scale, with 0 points given for an answer of yes, 2 for an answer of unsure, and 4 for an answer of no.
The total DCS score is the sum of the 10 items, multiplied by 2.5. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict)
The DCS can be conceptualized as subscores, which will be examined as a part of this study, and are normalized to a 0 to 100 score as above. These include the following:
Uncertainty subscore: 2 items (questions 9 and 10)
Informed subscore: 3 items (questions 1, 2, and 3)
Values clarity subscore: 2 items (questions 4 and 5)
Support subscore: 3 items (questions 6, 7, and 8)
Reference: https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf
Up to 18 months
Secondary Advance Directive Completion Completion of an advance directive, Physician Orders for Life-Sustaining Treatment (POLST), or both among patient-participants ascertained by participant query and/or chart review. 3 months
Secondary Canadian Health Care Evaluation Project (CANHELP) Questionnaire Score, Patients Change in score on the CANHELP Lite Patient Questionnaire version 11 Nov 2014 for patient-participants.
The CANHELP Lite Patient Questionnaire includes 21 items. One is a general question while the other 20 items inform 5 domains:
Domain #1: Relationship with doctors: Questions 2, 3, and 4 Domain #2: Illness Management: Q5 - 13 Domain #3: Communication: Q13 - 16 Domain #4: Decision Making: Q17 - 20 Domain #5: Feeling at Peace: Q21 Questions are scored on a 5-point scale, ranging from 'Not at All' to 'Completely'. The Overall Score is the unweighted average of all answered questions. Individual domain scores are the unweighted average of non-missing questions specific to each domain. All scores are subsequently re-scaled to range between 0 (worst possible value) and 100 (best possible value). The Overall Score will be the focus of analyses.
Ref: Heyland et al. J Pain Symptom Manage. 2013
3 months
Secondary Canadian Health Care Evaluation Project (CANHELP) Questionnaire Score, Carepartners Change in score on the CANHELP Lite Caregiver Questionnaire 11 Nov 2014 for carepartner participants.
The CANHELP Lite Caregiver Questionnaire includes 23 items. Two are general questions while the remaining 21 items inform 5 domains:
Domain #1: Relationship with doctors: Questions 3 - 5 Domain #2: Characteristics of Doctors and Nurses: Q6-7 Domain #3: Illness Management: Q8-16 Domain #4: Communication and Decision Making: Q17-20 Domain #5: Your Involvement: Q21-23
Questions are scored on a 5-point scale, ranging from 'Not at All' to 'Completely'. The Overall Score is the unweighted average of all answered questions. Individual domain scores are the unweighted average of non-missing questions specific to each domain. All scores are subsequently re-scaled to range between 0 (worst possible value) and 100 (best possible value). The Overall Score will be the focus of analyses.
Ref: Heyland et al. J Pain Symptom Manage. 2013
3 months
Secondary Canadian Health Care Evaluation Project (CANHELP) Questionnaire Score, Patients Change in score on the CANHELP Lite Patient Questionnaire version 11 Nov 2014 for patient-participants.
The CANHELP Lite Patient Questionnaire includes 21 items. One is a general question while the other 20 items inform 5 domains:
Domain #1: Relationship with doctors: Questions 2, 3, and 4 Domain #2: Illness Management: Q5 - 13 Domain #3: Communication: Q13 - 16 Domain #4: Decision Making: Q17 - 20 Domain #5: Feeling at Peace: Q21 Questions are scored on a 5-point scale, ranging from 'Not at All' to 'Completely'. The Overall Score is the unweighted average of all answered questions. Individual domain scores are the unweighted average of non-missing questions specific to each domain. All scores are subsequently re-scaled to range between 0 (worst possible value) and 100 (best possible value). The Overall Score will be the focus of analyses.
Ref: Heyland et al. J Pain Symptom Manage. 2013
Up to 18 months
Secondary Canadian Health Care Evaluation Project (CANHELP) Questionnaire Score, Carepartners Change in score on the CANHELP Lite Caregiver Questionnaire 11 Nov 2014 for carepartner participants.
The CANHELP Lite Caregiver Questionnaire includes 23 items. Two are general questions while the remaining 21 items inform 5 domains:
Domain #1: Relationship with doctors: Questions 3 - 5 Domain #2: Characteristics of Doctors and Nurses: Q6-7 Domain #3: Illness Management: Q8-16 Domain #4: Communication and Decision Making: Q17-20 Domain #5: Your Involvement: Q21-23
Questions are scored on a 5-point scale, ranging from 'Not at All' to 'Completely'. The Overall Score is the unweighted average of all answered questions. Individual domain scores are the unweighted average of non-missing questions specific to each domain. All scores are subsequently re-scaled to range between 0 (worst possible value) and 100 (best possible value). The Overall Score will be the focus of analyses.
Ref: Heyland et al. J Pain Symptom Manage. 2013
Up to 18 months
See also
  Status Clinical Trial Phase
Recruiting NCT06386172 - Electronic Decision-support System to Improve Detection and Care of Patients With Chronic Kidney Disease in Stockholm N/A
Recruiting NCT04910867 - APOL1 Genetic Testing Program for Living Donors N/A
Completed NCT03434145 - Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases N/A
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Terminated NCT05022329 - COVID-19 Vaccine Boosters in Patients With CKD Phase 2/Phase 3
Not yet recruiting NCT04925661 - HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia Phase 1
Recruiting NCT04961164 - Resistant Starch Prebiotic Effects in Chronic Kidney Disease N/A
Completed NCT05015647 - Low Protein Diet in CKD Patients at Risk of Malnutrition N/A
Completed NCT03426787 - Helping Empower Liver and Kidney Patients N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT04363554 - The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease N/A
Recruiting NCT04831021 - Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role? N/A
Terminated NCT04877847 - Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury N/A
Recruiting NCT04422652 - Combination of Novel Therapies for CKD Comorbid Depression Phase 2
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Not yet recruiting NCT06330480 - Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease N/A
Recruiting NCT03176862 - Left Ventricular Fibrosis in Chronic Kidney Disease N/A
Terminated NCT02539680 - Intestinal Phosphate Transporter Expression in CKD Patients N/A